Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients with Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study-Reference-Cited by-同舟云学术

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients with Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study

Published:2021-09 Issue: Volume:Volume 14 Page:6093-6099
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Liu Xiaoyu,Shi Hua,Shen Jing,Li Yang,Yan Wei^ORCID,Sun Ying,Liao Aijun,Tan Yehui,Yang Wei,Wang Huihan

Publisher

Informa UK Limited

Subject

General Medicine

Reference19 articles.

1. Acute myeloid leukemia in the elderly: therapeutic options and choice

2. Selecting initial treatment of acute myeloid leukaemia in older adults

3. Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults

4. Elderly Acute Myeloid Leukemia: Assessing Risk

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology;European Journal of Medical Research;2024-04-09

2. Pyroptosis in cancer treatment and prevention: the role of natural products and their bioactive compounds;Medical Oncology;2024-01-28

3. Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia;Cells;2023-04-11

4. Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells;Cancer Gene Therapy;2022-06-29